Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation

Cell

Volumn 90, Issue 5, 1997, Pages 917-927

  Li, Jinhe ^a   Xu, Min ^a   Zhou, Hui ^a   Ma, Jianyi ^a   Potter, Huntington ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CENTROMERE; CENTROSOME; CHROMOSOME SEGREGATION; CHROMOSOME STRUCTURE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030761059     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80356-6     Document Type: Article

References (71)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. Artavanis-Tsakonas, S., Matsuno, K., and Fortini, M.E. (1995). Notch signaling. Science 265, 225-232.
3. Ashall, F., and Goate, A.M. (1994). Role of the beta-amyloid precursor protein in Alzheimer's disease. Trends Biochem. Sci. 19, 42-46.
4. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., and Smith, J.A. (1989). Current Protocols in Molecular Biology. (New York: Greene Publishing Associates and Wiley-lnterscience).
5. Blair Zajdel, M.E., and Blair, G.D. (1988). The intracellulardistribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells. Oncogene 2, 579-584.
6. Brenner, S., Pepper, D., Berns, M.W., Tan, E., and Brinkley, B.R. (1981). Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients. J. Cell Biol. 91, 95-102.
7. Brown, M.S., and Goldstein, J.L. (1997). The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor. Cell 89, 331-340.
8. Busciglio, J., and Yankner, B.A. (1995). Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 375, 776-779.
9. Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997). Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Medicine 3, 67-72.
10. cdc2-type protein kinase. J. Biol. Chem. 267, 19035-19038.
11. Das, S.,and Potter, H. (1995). Expression of the Alzheimer amyloidpromoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14, 447-456.
12. Deng, G., Pike, C.J., and Cotman, C.W. (1996). Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Letters 397, 50-54.
13. De Strooper, B., Beullens, M., Contreras, B., Levesque, L., Craessaerts, K., Cordell, B., Moechars, D., Bollen, M., Fraser, P., St. George Hyslop, P., and Leuven, F. Van (1997). Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272, 3590-3598.
14. Dewji, N.N., and Singer, S.J. (1996). Genetic clues to Alzheimer's disease. Science 271, 159-160.
15. Doan, A., Thinakaran, G., Borchelt, D., Slunt, H.H., Ratovitsky, T., Podlisny, M., Selkoe, D.J., Seeger, M., Gandy, S.E., Price, D.L., and Sisodia, S.S. (1996). Protein topology of presenilin 1. Neuron 17, 1023-1030.
16. Donehower, L.A., Godley, L.A., Aldaz, C.M., Pyle, R., Shi, Y-P., Pinkel, D., Gray, J., Bradley, A., Medina, D., and Varmus, H.E. (1995). Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgeneic mice and promotes chromosomal instability. Genes Dev. 9, 882-895.
17. Duff, K., Eckman, C., Zher, C., Yu, X., Prada, C.-M., Perez-Tur, J., Hutton, M., Buee, L, Harigaya, Y., Yager, D., etal. (1996). Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 353, 710-713.
18. Elder, G.A., Tezapsidis, N., Carter, J., Shioi, J., Bouras, C., Li, H.-C., Johnston, J.M., Efthimiopoulos, S., Friedrich, V.L., Jr., and Robakis, N.K. (1996). Identification and neuron specific expression of the S182/presenilin 1 protein in human and rodent brains. J. Neurosci. 45, 308-320.
19. Fukawawa, K., Choi, T., Kuriyama, R., Rulong, S., Vande Woude, G.F. (1996). Abnormal centrosome amplification in the absence of p53. Science 271, 1744-1747.
20. Griffin, W.S.T., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White III, C.L., and Araoz, C., (1989). Brain interleukin-1 and S100 immunoreactivity elevated in Down's syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
21. Haass, C. (1996). Presenile because of presenilin: the presenilin genes and early onset Alzheimer's disease. Curr. Opin. Neurol. 9, 254-259.
22. Kamboh, M.I., Sanghera, O.K., Ferrell, R.E., and DeKosky, ST. (1995). ApoE4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nature Genet. 10, 486-488.
23. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J.W., Elledge, S., Nishimoto, T., Morgan, D.O., Franza, B.R., and Roberts, J. (1992). Formation and activation of acyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257, 1689-1694.
24. Kopan, R., Schroeter, E.H., Weintraub, H., and Nye, J.S. (1996). Signal transduction by activated mNotch: importance of proteolytic processing and its regulation bytheextracellular domain. Proc. Natl. Acad. Sci. USA 93, 1683-1688.
25. Kovacs, D.M., Fausett, H.J., Page, K.J., Kim, T.W., Moir, R.D., Merriam, D.E., Hollister, R.D., Hallmark, O.G., Mancini, R., Felsenstein, K.M., et al. (1996). Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2, 224-229.
26. LeBlanc, A. (1995). Increased production of 4KDa amyloid beta peptide in serum-deprived human primary neuron cultures: possible involvement of apoptosis. J. Neurosci. 15, 7837-7846.
27. Lengauer, G., Kinzler, K.W., and Vogelstein, B. (1997). Genetic instability on colorectal cancers. Nature 356, 623-630.
28. Levitan, D., and Greenwald, I. (1995). Facilitation of lin-72-mediated signaling by sel-12, a Caenorhabditis elegans S182Alzheimer's disease gene. Nature 377, 351-354.
29. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.-E., Jondro, P.D., Schmidt, S.D., Wang, K., et al. (1995a). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-976.
30. Levy-Lahad, E., Wijsman, E.M., Nemens, E., Anderson, L., Goddard, K.A.B., Weber, J.L., Bird, T.D., and Schellenberg, G.D. (1995b). A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
31. Li,X., and Greenwald, I. (1996). Mem brane topology of the C. elegans sel-12 presenilin. Neuron 17, 1015-1021
32. Li, J., Ma, J., and Potter, H. (1995). Identification and expression analysis of a potential familial Alzheimer's diseasegene on chromosome 1 related to AD3. Proc. Natl. Acad. Sci. USA 92, 12180-12184.
33. Ma, J., Yee, A., Brewer, H.B., Das, S., and Potter, H. (1994). Amyloidassociated proteins (1,-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
34. Ma, J., Brewer, H.B., Jr., and Potter, H. (1996). Alzheimer Aβ neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides. Neurobiol. Aging 17, 773-780.
35. Martins, R.N., Turner, B.A., Carrol I, R.T., Sweeney, D., Kim, K.S., Wisniewski, H.M., Blass, J.P., Gibson, G.E., and Gandy, S. (1995). High levels of amyloid- protein from S182 (Glu246) familial Alzheimer's cells. NeuroReport 7, 217-220.
36. McKeon, F.D., Tuffanelli, D.L., Fukuyama, K., and Kirschner, M.W. (1983). Autoimmune response directed against conserved determinants on nuclear envelope proteins in a patient with linear scleroderma. Proc. Natl. Acad. Sci. USA SO, 4374-4378.
37. Mercken, M., Takahashi, H., Honda, T., Sato, K., Murayama, M., Nakazato, Y., Noguchi, K., Imahori, K., and Takashima, A. (1996). Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett. 359, 297-303.
38. Mitchell, A.R. (1996). The mammalian centromere: its molecular architecture. Mutation Research 372, 153-62.
39. Moroi, Y., Hartman, A.L., Nakane, P.K., and Tan, E.M. (1981). Distribution of kinetochore (centromere) antigen in mammalian cell nuclei. J. Cell Biol. 90, 254-259.
40. Moussaoui, S., Czech, C., Pradier, L., Blanchard, V., Bonici, B., Gohin, M., Imperato, A., and Revah, F. (1996). Immunohistochemical analysis of presenilin-1 expression in the mouse brain. FEBS Lett. 353, 219-222.
41. Potter, H. (1991). Review and hypothesis: Alzheimer disease and Down syndrome-chromosome 21 nondisjunction may underlie both disorders. Am. J. Hum. Genet. 48, 1192-1200.
42. Potter, H., and Geller, L.N. (1996). Alzheimer's disease, Down's syndrome, and chromosome segregation. The Lancet 346, 66.
43. Potter, H., Weir, L., and Leder, P. (1984). Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA 81, 7161-7165.
44. Potter, H., Ma, J., Das, S., Geller, L.N., Benjamin, M., Kayyali, U.S. and Dressler, D. (1995). Beyond β-protein: new steps in the pathogenic pathway to Alzheimer's disease. In Research Advances in Alzheimer's Disease and Related Disorders, K. Iqbal, J.A. Mortimer, B. Winblad, and W.H. Wisniewski, eds. (New York: John Wiley and Sons, pp. 643-654).
45. Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, G., Holman, K., Tsuda, T., et al. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
46. Sanan, D.A., Weisgraber, K.H., Russell, S.J., Mahley, R.W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., Roses, A.D., and Strittmatter, W.J. (1994). Apolipoprotein E associates with amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94, 860-869.
47. Schellenberg, G.D. (1995). Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc. Natl. Acad. Sci. USA 92, 8552-8559.
48. Schellenberg, G.D., Bird, T.D., Wijsman, E.M., Orr, H.T., Anderson, L., Nemens, E., White, J.A., Bonnycastle, L., Weber, J.L., Alonso, M., et al. (1993). Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 668-671.
49. Scheuner, D., Eckman, C., Jensen, M., and Younkin, S. (1996). Secreted amyloid b-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Medicine 2, 864-870.
50. Schweber, M. (1985). A possible unitary genetic hypothesis for Alzheimer's disease and Down syndrome. Ann. NY Acad. Sci. 450, 223-238.
51. Selkoe, D.J. (1994). Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10, 373-103.
52. Shen, J., Bronson, R.T., Chen, D.F., Xia, W., Selkoe, D.J., and Tonegawa, S. (1997). Skeletal and CNS defects in presenilin-1-deficient mice. Cell 89, 629-639.
53. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, G., Li, G., Holman, K. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
54. Stone, J.F., and Sandberg, A.A. (1995). Sex chromosome aneuploidy and aging. Mutation Res. 338, 107-113.
55. Strittmatter, W.J., and Roses, A.D. (1995). Apolipoprotein E and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 92, 4725-4727.
56. Suzuki, M. (1989). SPXX, a frequent sequence motif in gene regulatory proteins. J. Mol. Biol. 207, 61-84.
57. Takashima, A., Sato, M., Mercken, M., Tanaka, S., Kondo, S., Honda, T., Sato, K., Murayama, M., Noguchi, K., Nakazato, Y., and Takahashi, H. (1996). Localization of Alzheimer-associated presenilin 1 in transfected COS-7 cells. Biochem. Biophys. Res. Comm. 227, 423-26.
58. Teller, J.K., Russo, G., DeBusk, L.M., Angelini, G., Zaccheo, D., Dagna-Bricarelli, F., Scartezzini, P., Bertolini, S., Mann, D.M.A., Tabaton, M., and Gambetti, P. (1996). Presence of soluble amyloid -peptide precedes amyloid plaque formation in Down's syndrome. Nature Medicine 2, 93-95.
59. Thinakaran, G., Borchelt, D.R., Lee, M.K., Slunt, H.H., Spitzer, L., Kim, G., Slunt, H.H., Spitzer, L., Kim, G., Ratovitsky, T., et al. (1996). Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
60. Tuffanelli, D.L., McKeon, F., Kleinsmith, D.M., Burnham, T.K. and Kirschner, M. (1983). Anti-centrosome and anti-centriole antibodies in the scleroderma spectrum. Arch. Dermatol. 119, 560-566.
61. Varmus, H., and Weinberg, R. (1993). Genes and the Biology of Cancer (New York: Scientific American Library).
62. Vincent, I., Rosado, M., and Davies, P. (1996). Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132, 413-425.
63. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521-525.
64. Vito, P., Wolozin, B., Ganjei, J.K., Iwasaki, K., Lacana, E., and D'Adamio, L. (1996b). Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. J. Biol. Chem. 271, 31025-31028.
65. Walter, J., Capell, A., Grünberg, J., Pesold, B., Schindzielorz, A., Prior, R., Podlisny, M.B., Fraser, P., St. George-Hyslop, P., Selkoe, D.J., and Haas, C. (1996). The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2, 673-691.
66. Westendorf, J.M., Rao, P.N.,and Gerace, L. (1994). Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. Proc. Natl. Acad. Sci. USA 91, 714-718.
67. Winey, M., Hoyt, M.A., Chan, C., Goetsch, L., Botstein, D., and Byers, B. (1993). NDC1 : a nuclear periphery component required for yeasts spindle pole body duplication. J. Cell Biol. 122, 743-751.
68. Wisniewski, T., Castano, E.M., Golabek, A., Vogel, T., and Frangione, B. (1994). Acceleration of Alzheimer's fibril formation byapolipoprotein Ein vitro. Am. J. Pathol. 145, 1030-1035.
69. Wolozin, B., Iwasaki, K., Vito, P., Ganjei, J.K., Lacan'a, E., Sunderland, T., Zhao, B., Kusiak, J.W., Wasco, W., D'Adamio, L. (1996). Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713.
70. Yankner, B.A. (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
71. Ye, Q., and Worman, H.J. (1994). Primary structure analysis and lamin B and DNA binding of human LBR, an integral protein of the nuclear envelope inner membrane. J. Biol. Chem. 269, 11306-11311.